17-247202-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006987.4(RPH3AL):c.522C>A(p.Asp174Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,613,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006987.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPH3AL | NM_006987.4 | c.522C>A | p.Asp174Glu | missense_variant | 7/10 | ENST00000331302.12 | NP_008918.1 | |
RPH3AL | NM_001190411.2 | c.522C>A | p.Asp174Glu | missense_variant | 6/9 | NP_001177340.1 | ||
RPH3AL | NM_001190412.2 | c.435C>A | p.Asp145Glu | missense_variant | 6/9 | NP_001177341.1 | ||
RPH3AL | NM_001190413.2 | c.435C>A | p.Asp145Glu | missense_variant | 5/8 | NP_001177342.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251228Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135784
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461728Hom.: 0 Cov.: 31 AF XY: 0.0000206 AC XY: 15AN XY: 727156
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152196Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2024 | The c.522C>A (p.D174E) alteration is located in exon 7 (coding exon 5) of the RPH3AL gene. This alteration results from a C to A substitution at nucleotide position 522, causing the aspartic acid (D) at amino acid position 174 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at